Large-Scale Manufacturing for Reproducible iPSC-Based Drug Screening

This poster presents Ncardia’s large-scale manufacturing platform for producing reproducible, high-quality iPSC-derived cellular models designed to support multi-year drug screening programs with consistent assay performance and scalable supply.

Download it now for a closer look at:

• How fully controlled stirred-tank bioreactor manufacturing enables reliable large-batch production of iPSC-derived cell models at industrial scale 
  
• How data-driven monitoring of critical process and quality attributes supports reproducibility, consistency, and long-term assay stability
• Characterization data across multiple iPSC-derived models, including ventricular and atrial cardiomyocytes, NHP cardiomyocytes, microglia, and 3D cardiac microtissues
• Functional assay data demonstrating physiologically relevant responses to pharmacological compounds across electrophysiology, contractility, calcium handling, and inflammatory readouts

• How standardized yet flexible manufacturing workflows support tailored differentiation strategies while maintaining robust batch-to-batch consistency